Back to Search
TYLER ANDRE, M.D.
M.D.
Emergency Medicine Physician
NPI: 1750648390IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
4301105636(MI)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 2014
Research & Publications (13)
Determining the effectiveness of the usability problem inspector: a theory-based model and tool for finding usability problems.
PMID 14702996·Hum Factors·2003
4-observational
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.
PMID 19124803·J Clin Oncol·2009
8-other
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer.
PMID 18400508·Crit Rev Oncol Hematol·2008
8-other
[Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma in 2006].
PMID 17237007·Bull Cancer·2007
6-review
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
PMID 16943526·J Clin Oncol·2006
8-other
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.
PMID 16260700·J Clin Oncol·2005
4-observational
Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer.
PMID 15459217·J Clin Oncol·2004
3-trial
An overview of adjuvant systemic chemotherapy for colon cancer.
PMID 15212702·Clin Colorectal Cancer·2004
6-review
Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.
PMID 14581421·J Clin Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4610 X ST
SACRAMENTO, CA 95817 - Phone
- (949) 293-5700
Quick Facts
- NPI
- 1750648390
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 12
- Publications
- 13
Are you this provider?
Claim Your Profile